Lifevantage Corp
LFVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000849146
In the last 90 days, Lifevantage Corp insiders filed 1 open-market purchase and 1 sale; 88 institutions reported holding it in 13F filings for Q2 2026, worth $36.9M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Lifevantage Corp changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 52 | 56 | +4 |
| Shares | 2.95M | 2.98M | +36.9K (+1.3%) |
| Value | $17.8M | $19.2M | +$1.32M (+7.4%) |
New holders (5)
Institutions that held Lifevantage Corp at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Independent Financial Group, LLC | 16,647 | $106.9K | 0.00% |
| ICA Group Wealth Management, LLC | 500 | $3.21K | 0.00% |
| Bank of America Corp | 153 | $982 | 0.00% |
| Jones Financial Companies LLLP | 100 | $642 | 0.00% |
| Innealta Capital, LLC | 3 | $19 | 0.00% |
Sold out (1)
Institutions that held Lifevantage Corp at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 15,296 | $92.5K |